Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation

This article was originally published in The Tan Sheet

Executive Summary

A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.
Advertisement

Related Content

Sports Supplement Steroid Metabolites Targeted By AMA
Sports Supplement Steroid Metabolites Targeted By AMA
White House Sports Drug Task Force Preliminary Report Expected Early 2001
Andro
Creatine Use Discouraged Due To Sparse Research, Potential AEs
Andro study
Met-Rx, AST To Place Warnings On "Andro" Products Under FTC Settlement
McGwire gives up andro
McGwire gives up andro
Andro Does Not Boost Muscle Mass Or Serum Testosterone Levels - Study

Topics

Advertisement
UsernamePublicRestriction

Register

PS091036

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel